B-Cell Malignant Neoplasm — Research

B-Cell Malignant Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed14 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-28	47,101	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab])`	2026-09-28	pubmed
Last 5 years	2021-01-01 → 2026-12-31	17,686	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-28	pubmed
Preceding 5-year window	2020-09-28 → 2025-09-27	15,190	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2020/09/28:2025/09/27[dp])`	2026-09-28	pubmed
Last 12 months	2025-09-28 → 2026-09-28	3,664	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2025/09/28:2026/09/28[dp])`	2026-09-28	pubmed
y2016	2016-01-01 → 2016-12-31	2,362	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2016/01/01:2016/12/31[dp])`	2026-09-28	pubmed
y2017	2017-01-01 → 2017-12-31	2,535	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2017/01/01:2017/12/31[dp])`	2026-09-28	pubmed
y2018	2018-01-01 → 2018-12-31	2,868	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2018/01/01:2018/12/31[dp])`	2026-09-28	pubmed
y2019	2019-01-01 → 2019-12-31	2,848	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2019/01/01:2019/12/31[dp])`	2026-09-28	pubmed
y2020	2020-01-01 → 2020-12-31	2,984	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2020/01/01:2020/12/31[dp])`	2026-09-28	pubmed
y2021	2021-01-01 → 2021-12-31	3,279	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2021/01/01:2021/12/31[dp])`	2026-09-28	pubmed
y2022	2022-01-01 → 2022-12-31	3,264	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2022/01/01:2022/12/31[dp])`	2026-09-28	pubmed
y2023	2023-01-01 → 2023-12-31	3,207	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2023/01/01:2023/12/31[dp])`	2026-09-28	pubmed
y2024	2024-01-01 → 2024-12-31	3,237	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2024/01/01:2024/12/31[dp])`	2026-09-28	pubmed
y2025	2025-01-01 → 2025-12-31	3,718	`("B-Cell Malignant Neoplasm"[tiab] OR "B-cell lymphoma"[tiab] OR "B-Cell Malignancy"[tiab]) AND (2025/01/01:2025/12/31[dp])`	2026-09-28	pubmed

Data updated 2 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (278)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 226–250 of 278 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Unusual PDGFRB fusion reveals novel mechanism of kinase activation in Ph-like B-ALL.
· Leukemia · 2023 · PMID 36810896 · validated civic_curation pubmed
Crizotinib in refractory ALK-positive diffuse large B-cell lymphoma: a case report with a short-term response.
· Eur J Haematol · 2014 · PMID 24330038 · validated civic_curation pubmed
Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia.
· Pediatr Blood Cancer · 2017 · PMID 27860260 · validated civic_curation pubmed
NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.